Also on the agenda for day one at the Academy of Managed Care Pharmacy (AMCP) 24th Annual Meeting in San Francisco was a satellite symposium that focused on analyzing and applying evidence to improve the cost/benefit and risk/benefit outcomes in multiple sclerosis. One of the overarching themes throughout the 5 presentations that comprised the program was medication adherence.
Wednesday morning at the Academy of Managed Care Pharmacy 24th Annual Meeting featured a satellite symposium that focused on the evolving role of managed care and oncology pharmacy management. The presentations by distinguished faculty reviewed current evidence-based data to enable decision making based on indicators of treatment outcomes for multiple myeloma; demonstrated the use of comparative effectiveness research (CER) as a decision support tool; and evaluated innovative pharmacy benefit models and specialty management services.
Keynote session discussed healthcare reform and implications for managed care pharmacy.
Conference session discussed anticoagulation care, stroke prevention, and management of thromboembolic disorders.
Pre-conference program provided recommendations for oncology pharmacy management strategies.
Pre-conference session tackled controversial topic of healthcare reform.
Our coverage from the Academy of Managed Care Pharmacy's 23rd Annual Meeting & Showcase.